By Chip Brian, SmarTrend Analytics Team
01/08/2010-NuVasive (NASDAQ:NUVA) was initiated at Rodman & Renshaw Friday with a Market Perform.
The firm says NuVasive’s position as the #5 player in spine surgery sector mandates its rating.
Furthermore, the firm says the spine surgery sector currently is valued at $8 billion and has favorable growth drivers such as the aging population and rising obesity behind it.
However, the firm remains cautious due to its belief that a market-wide shock could have a multiplier effect on NuVasive given its lack of diversification.
